Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-22-016158
Filing Date
2022-02-09
Accepted
2022-02-09 14:38:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm225659d34_sc13ga.htm SC 13G/A 38889
  Complete submission text file 0001104659-22-016158.txt   40386
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Subject) CIK: 0001652130 (see all company filings)

EIN.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89486 | Film No.: 22605923
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 200 CENTRAL AVENUE ST. PETERSBURG FL 33701
Business Address 200 CENTRAL AVENUE ST. PETERSBURG FL 33701 212-426-7040
ARK Investment Management LLC (Filed by) CIK: 0001697748 (see all company filings)

EIN.: 464309299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A